Sun Pharma acquires 60% stake in Vivaldis Health & Foods for 143 cr
The remaining 40 per cent shareholding will be acquired in future as per certain terms and conditions, said Sun Pharmaceutical in its regulatory filing.24-03-2023
24-03-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Acquisition
This is to inform you that Sun Pharmaceutical Industries Limited (which includes its subsidiaries and/or associate companies) ('Company') has entered into an agreement to acquire 60% shareholding in Vivaldis Health And Foods Private Limited from its existing shareholders with remaining 40% shareholding to be acquired in future as per certain terms & conditions. The particulars of the disclosure required as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, are provided in Annexure A as enclosed herewith. This is for your information and dissemination.24-03-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201522-03-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith our Press Release relating to 'Osteoarthritis Candidate MM-II Showed Durable Pain Relief in Global Phase 2b Study', which we shall be releasing after sending this letter to you. This submission is being made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is for your information and dissemination.22-03-2023
Markets stay firm ahead of Fed policy; Auto, healthcare stocks led rally; Bajaj twins, Sun Pharma top gainers
Vinod Nair, Head of Research at Geojit Financial Services said, staying afloat in a volatile trade, the domestic market managed to remain positive, with the optimism that the global banking system issue is behind us.22-03-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 22, 2023 for Raksha Sudhir Valia22-03-2023
Mumbai is home to 66 billionaires, Byju Raveendran's wealth at $3.3 bn: Key findings from Hurun Global Rich List
With a wealth of $27 billion, Cyrus Poonawalla of Serum Institute of India is the richest healthcare billionaire in the world followed by Dilip Shanghvi & family of Sun Pharmaceutical Industries, who have a net worth of around $17 billion.22-03-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201519-03-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith our Press Release relating to 'Late-Breaking Phase 3 Data at AAD 2023 Show Oral Investigational Medicine Deuruxolitinib Significantly Improved Scalp Hair Regrowth in Alopecia Areata', which we shall be releasing after sending this letter to you. This is for your information and dissemination.19-03-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201516-03-2023